Edwards Lifesciences Corp (EW) stock
EWNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/3057% above fair value
$105.80−0.01 (-0.01%)
Close on Nov 12, 2026Market cap $60.98BP/E 59.8Yield –
Edwards Lifesciences profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Edwards Lifesciences's profit margin for the twelve months ending Sep 30, 2026 was 15.3%. For fiscal 2025 it was 17.7%, against 76.7% the year before. The highest annual figure on record is 76.7% in fiscal 2024.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 17.7% | −59.1 |
| FY2024 | Dec 31, 2024 | 76.7% | +48.8 |
| FY2023 | Dec 31, 2023 | 28.0% | −6.1 |
| FY2022 | Dec 31, 2022 | 34.1% | +5.4 |
| FY2021 | Dec 31, 2021 | 28.7% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 17.9% | −0.8 |
| Q2 FY2026 | Jun 30, 2026 | 13.9% | −7.9 |
| Q1 FY2026 | Mar 31, 2026 | 23.1% | −2.2 |
| Q4 FY2025 | Dec 31, 2025 | 5.8% | −22.0 |
| Q3 FY2025 | Sep 30, 2025 | 18.7% | −208.0 |
| Q2 FY2025 | Jun 30, 2025 | 21.7% | −5.0 |
| Q1 FY2025 | Mar 31, 2025 | 25.3% | −1.1 |
| Q4 FY2024 | Dec 31, 2024 | 27.8% | −1.4 |
| Q3 FY2024 | Sep 30, 2024 | 226.7% | +195.8 |
| Q2 FY2024 | Jun 30, 2024 | 26.7% | +2.7 |
| Q1 FY2024 | Mar 31, 2024 | 26.5% | −1.4 |
| Q4 FY2023 | Dec 31, 2023 | 29.2% | −63.5 |
| Q3 FY2023 | Sep 30, 2023 | 31.0% | +4.9 |
| Q2 FY2023 | Jun 30, 2023 | 24.0% | −5.6 |
| Q1 FY2023 | Mar 31, 2023 | 27.9% | – |
| Q4 FY2022 | Dec 31, 2022 | 92.7% | – |
| Q3 FY2022 | Sep 30, 2022 | 26.0% | – |
| Q2 FY2022 | Jun 30, 2022 | 29.6% | – |
See a number that looks wrong?